Analyst Reco. Bayer AG

Equities

Market Closed - Xetra Other stock markets 16:35:12 05/06/2026 BST			5-day change	1st Jan Change
36.16 ^EUR	+1.69%		-1.01%	-2.30%

06-05	Study: Bayer's Finerenone slows progression of chronic kidney disease	RE
06-05	Bayer Announces Phase III FIND-CKD Results For KERENDIA In Non-Diabetic Chronic Kidney Disease	CI

06-05	BAYER AG : UBS maintains a Buy rating	ZD
06-05	UBS maintains 'Buy' rating on Bayer - Target 52 euros	DP
06-03	AlphaValue/Baader Europe Upgrades Bayer to Buy, Trims PT	MT
06-03	Mwb Says Bayer Valuation Discounts US Legal Overhang; Buy Rating Kept	MT
06-03	Bayer Rating Maintained at Buy as BofA Notes Transfer of Roundup Class Action Lawsuit	MT
05-29	Bayer stock in the red as market scrutinizes legal disputes
05-29	BAYER AG : Jefferies gives a Neutral rating	ZD
05-29	Jefferies raises Bayer target to 40 euros, 'Hold' - New analyst	DP
05-28	BAYER AG : UBS remains its Buy rating	ZD
05-19	BAYER AG : DZ Bank takes a positive view	ZD
05-19	DZ Bank upgrades Bayer to 'Buy' - Fair value raised to 51 euros	DP
05-19	BAYER AG : Receives a Buy rating from Barclays	ZD
05-19	Barclays raises Bayer price target to 50 euros - 'Overweight'	DP
05-15	BMO Revises Estimates for Bayer Post-Q1 Results; Market Perform Rating Kept	MT
05-14	Bayer Kept at Buy as Mwb Notes 'Solid' Q1 Results	MT
05-14	BAYER AG : JP Morgan maintains a Buy rating	ZD
05-13	BAYER AG : Deutsche Bank sticks Neutral	ZD
05-13	BAYER AG : UBS gives a Buy rating	ZD
05-13	Bayer Kept at Market Perform as BMO Notes One-time Seed Licensing Boost in Q1	MT
05-12	Bayer: An assuring quarter towards gradual transformation
05-12	BAYER AG : Gets a Buy rating from Barclays	ZD
05-12	BAYER AG : JP Morgan remains its Buy rating	ZD
05-12	JPMorgan maintains 'Overweight' rating on Bayer - Target 50 euros	DP
05-08	BAYER AG : UBS maintains a Buy rating	ZD
05-08	UBS maintains 'Buy' rating on Bayer - Target 52 euros	DP